‘Pharma Bro’ Shkreli Violated Lifetime Ban And Should Be Sanctioned, FTC Says

Updated Jan 20, 2023, 04:50pm EST Topline The Federal Trade Commission is asking a federal judge to sanction former hedge fund manager Martin Shkreli, arguing he should be held in contempt for violating his lifetime ban from the pharmaceutical industry by founding a company named Druglike, touted as a “drug discovery platform.” Key Facts Shkreli

Related Articles

Leave a Reply

Your email address will not be published.

Back to top button